Pregnancy Products Market Size and Share

Pregnancy Products Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Pregnancy Products Market Analysis by Mordor Intelligence

The pregnancy products market size reached USD 2.53 billion in 2025 and is forecast to climb to USD 3.37 billion by 2030, expanding at a 5.88% CAGR. The pregnancy products market benefits from widening employer-funded family-building benefits, rapid uptake of artificial-intelligence fetal-monitoring wearables, and a booming e-pharmacy channel that removes distance barriers for rural consumers. Consumer migration toward flavorful prenatal gummies, rising venture-capital inflows into maternal-health start-ups, and corporate ESG commitments to clean-label stretch-mark topicals further extend the pregnancy products market runway. FDA clearances for wireless fetal monitors and mainstream adoption of digital pregnancy-test kits shorten traditional care pathways, reinforcing adoption among digitally engaged mothers. Competitive intensity remains moderate, with multinational healthcare conglomerates leveraging omnichannel footprints while direct-to-consumer newcomers use transparency and subscription models to win loyalty in the pregnancy products market.

Key Report Takeaways

  • By product type, prenatal supplements held 39.18% of pregnancy products market share in 2024, whereas prenatal monitoring devices are projected to expand at a 6.78% CAGR through 2030.
  • By stage, the pregnancy phase commanded 53.78% of the pregnancy products market size in 2024, while the pre-conception segment is poised for a 5.86% CAGR to 2030.
  • By distribution channel, pharmacies and drug stores captured 48.82% of the pregnancy products market size in 2024; online retail is forecast to grow at a 5.94% CAGR over 2025-2030.
  • By geography, North America led with a 35.23% revenue share in 2024, yet Asia-Pacific is set to post the fastest 6.11% CAGR through 2030.

Segment Analysis

By Product Type: Supplements Lead, Monitoring Devices Accelerate

Prenatal supplements captured 39.18% pregnancy products market share in 2024, underscoring clinical consensus on folic-acid, iron, and choline intake. Pharmacies leverage pharmacist counseling and employer benefit cards to drive steady unit turnover. AI-powered apps that remind mothers of dosing windows further bolster compliance, extending lifetime value across refill cycles. In contrast, FDA-cleared wireless monitors position prenatal monitoring devices for a 6.78% CAGR, with hospitals integrating at-home data feeds into electronic records to reduce clinic visits. Early adopters tout improved high-risk pregnancy surveillance, propelling hospital procurement budgets and direct-to-consumer purchases. Pregnancy detection kits maintain baseline demand, especially in emerging economies where clinic access is limited. Clean-label stretch-mark creams ride ESG tailwinds, while maternity wear navigates cost pressure by bundling with merchandise return schemes. High-density memory-foam pregnancy pillows and luxury postpartum recovery kits fill discretionary niches, complementing core health categories and rounding out the pregnancy products market.

Pregnancy Products Market: Market Share by Product Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Stage: Pregnancy Dominates, Pre-conception Gains Momentum

The pregnancy stage accounted for 53.78% of pregnancy products market size in 2024, reflecting nine months of continuous demand across supplements, monitors, and apparel. Hospital discharge packs often bundle sample vitamins and creams, deepening brand exposure. Tele-obstetrics platforms integrate fetal monitor rentals and digital nutrition plans, further anchoring consumption. Pre-conception is forecast to expand at a 5.86% CAGR, powered by fertility-benefit coverage that reimburses ovulation predictors, genetic testing, and nutrient preload kits. Employers that subsidize egg freezing widen the customer funnel well before conception, lengthening product journeys in the pregnancy products market. Post-partum remains under-served, but interest in lactation aids, pelvic-floor trainers, and overnight care packages is rising, illustrated by luxury retreats in New York and San Francisco offering bundled recovery services. Payors like UnitedHealthcare will reimburse doula support from 2026, signaling formal recognition of holistic care needs[2]Source: UnitedHealthcare, “New Doula Support Benefit Designed to Offer Employees Additional Support,” uhc.com.

By Distribution Channel: Pharmacies Prevail, Online Retail Surges

Pharmacies and drug stores retained 48.82% share of the pregnancy products market size in 2024, aided by pharmacist credibility and rapid access to time-sensitive items such as nausea relief and iron supplements. Chain pharmacies add point-of-care labs and vaccination booths, drawing sustained footfall. Online retail, however, is set for a 5.94% CAGR as direct-to-consumer brands exploit quizzes, tele-chat, and subscription refills to bypass physical shelf limits. Ritual’s transparency-centric model crossed USD 250 million annual revenue, proving online scalability. Counterfeit risks persist on open marketplaces, pushing shoppers toward brand-owned sites with batch verification. Supermarkets serve budget-conscious households by bundling prenatal staples within weekly grocery runs, while specialty boutiques cater to premium shoppers seeking curated assortments and expert fittings.

Pregnancy Products Market: Market Share by Distribution Channel
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

North America commands 35.23% of 2024 revenue thanks to broad insurance coverage, employer fertility perks, and cultural acceptance of proactive maternal care. Digital-health partnerships like Maven Clinic reduced NICU admissions by 40% and emergency visits by 33% for enterprise clients, demonstrating tangible ROI. E-pharmacy fulfillment centers support same-day prenatal deliveries, embedding convenience within the pregnancy products market. Regulatory alertness, however, stays high as GAO tests reveal label inaccuracies and the FDA increases inspections.  

Asia-Pacific is projected to deliver the highest 6.11% CAGR through 2030, buoyed by urbanization, rising disposable income, and government investments in maternal health. Local brands tailor herbal prenatal formulas to cultural diets, while multinationals localize SKUs and partner with e-pharmacy giants to reach tier-2 cities.  

Europe maintains steady growth fueled by sustainability-led innovation. L’Oréal’s eco-designed stretch-mark creams and traceable sourcing frameworks set category standards, while GDPR dictates stringent data-handling rules for digital monitors. Birth-rate declines encourage companies to widen lifetime value by upselling postpartum and menopause solutions, merging women’s health lines under unified brand roofs. South America and Middle East & Africa remain nascent yet promising, given youthful demographics and improving digital infrastructure; however, supply-chain fragmentation and price sensitivity necessitate tiered-pricing strategies to unlock full potential of the pregnancy products market.

Pregnancy Products Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

The pregnancy products market is moderately fragmented. Prenatal supplements feature low entry barriers, enabling influencer-led start-ups to coexist with healthcare conglomerates. Johnson & Johnson leverages global logistics to keep price points competitive, while newcomers anchor differentiation in clean sourcing and clinically backed claims. FDA scrutiny of label accuracy raises compliance costs, potentially accelerating consolidation as smaller brands struggle to fund testing.  

In prenatal monitoring devices, regulatory hurdles concentrate share among technology specialists. GE Healthcare and Bloomlife enjoy first-mover advantages following FDA approvals, whereas smaller entrants seek hospital partnerships to pilot AI algorithms. Venture-capital funds quadrupled maternal-health investments between 2022-2024, aiming to integrate devices, tele-obstetrics, and analytics into cohesive ecosystems.  

Quality accreditation and ESG credentials now decide shelf prominence. Brands that publish contaminant assays and measure carbon footprints receive retailer preference and corporate-benefit inclusion. As integrated care bundles that span fertility to postpartum gain traction, market players capable of orchestrating multi-product portfolios stand to outpace single-category specialists, even as new compliance rules tighten the pregnancy products industry.

Pregnancy Products Industry Leaders

  1. Abbott

  2. Clarins Group

  3. Expansxience Laboratories Inc.

  4. Nine Naturals LLC

  5. Noodle & Boo

  6. *Disclaimer: Major Players sorted in no particular order
Pregnancy Products Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • June 2025: Nestlé announced women’s health as a new growth platform, launching Materna DHA in Asia-Pacific and planning India expansion to align with local regulations.
  • April 2025: UnitedHealthcare will introduce a Doula Support benefit for self-insured employers, reimbursing labor support services.

Table of Contents for Pregnancy Products Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising penetration of OTC digital pregnancy-test kits in emerging economies
    • 4.2.2 Mainstream shift toward prenatal gummy formats in North America & Europe
    • 4.2.3 E-pharmacy boom lowering access barriers for rural expectant mothers
    • 4.2.4 Growth in employer-funded maternal-wellness benefits packages
    • 4.2.5 AI-enabled fetal-monitoring wearables gaining clinical validation
    • 4.2.6 Corporate ESG pressure favouring clean-label stretch-mark topicals
  • 4.3 Market Restraints
    • 4.3.1 Increasing reports of mislabeled prenatal supplements
    • 4.3.2 Price inflation across maternity wear supply chains
    • 4.3.3 Fake/grey-market pregnancy-test kits on e-commerce platforms
    • 4.3.4 Low prenatal-vitamin adherence in low-literacy populations
    • 4.3.5 Value / Supply-Chain Analysis
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porter’s Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Suppliers
    • 4.6.3 Bargaining Power of Buyers
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Competitive Rivalry Intensity

5. Market Size & Growth Forecasts

  • 5.1 By Product Type (Value)
    • 5.1.1 Prenatal Supplements
    • 5.1.2 Pregnancy Detection Kits
    • 5.1.3 Stretch-Mark Care Products
    • 5.1.4 Maternity Wear
    • 5.1.5 Pregnancy Pillows
    • 5.1.6 Prenatal Monitoring Devices
    • 5.1.7 Post-partum Care Products
  • 5.2 By Stage (Value)
    • 5.2.1 Pre-conception
    • 5.2.2 Pregnancy
    • 5.2.3 Post-partum
  • 5.3 By Distribution Channel (Value)
    • 5.3.1 Supermarkets / Hypermarkets
    • 5.3.2 Pharmacies & Drug Stores
    • 5.3.3 Online Retail
    • 5.3.4 Specialty Stores
  • 5.4 By Geography (Value)
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 United Kingdom
    • 5.4.2.2 Germany
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 GCC
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Procter & Gamble Co.
    • 6.3.2 Johnson & Johnson
    • 6.3.3 Church & Dwight Co. Inc.
    • 6.3.4 Bayer AG
    • 6.3.5 Abbott Laboratories
    • 6.3.6 Reckitt Benckiser Group plc
    • 6.3.7 Nestlé S.A.
    • 6.3.8 Kimberly-Clark Corporation
    • 6.3.9 Vitabiotics Ltd.
    • 6.3.10 Prestige Consumer Healthcare Inc.
    • 6.3.11 Lansinoh Laboratories Inc.
    • 6.3.12 Medela AG
    • 6.3.13 Frida Holdings LLC
    • 6.3.14 Koninklijke Philips N.V.
    • 6.3.15 Owlet Inc.
    • 6.3.16 Ameda AG
    • 6.3.17 Hain Celestial Group Inc.
    • 6.3.18 Perrigo Company plc

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Pregnancy Products Market Report Scope

Pregnancy products deal with the physical changes of pregnant women during and after pregnancy. The Pregnancy Products Market is Segmented by Product (Stretch Mark Minimizers, Pregnancy Test Kits, Toning and Body Firming Gel, Restructuring Gel, and Other Products), Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Drug Stores, and Online), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type (Value)
Prenatal Supplements
Pregnancy Detection Kits
Stretch-Mark Care Products
Maternity Wear
Pregnancy Pillows
Prenatal Monitoring Devices
Post-partum Care Products
By Stage (Value)
Pre-conception
Pregnancy
Post-partum
By Distribution Channel (Value)
Supermarkets / Hypermarkets
Pharmacies & Drug Stores
Online Retail
Specialty Stores
By Geography (Value)
North America United States
Canada
Mexico
Europe United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
By Product Type (Value) Prenatal Supplements
Pregnancy Detection Kits
Stretch-Mark Care Products
Maternity Wear
Pregnancy Pillows
Prenatal Monitoring Devices
Post-partum Care Products
By Stage (Value) Pre-conception
Pregnancy
Post-partum
By Distribution Channel (Value) Supermarkets / Hypermarkets
Pharmacies & Drug Stores
Online Retail
Specialty Stores
By Geography (Value) North America United States
Canada
Mexico
Europe United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the pregnancy products market?

The pregnancy products market size stands at USD 2.53 billion in 2025 and is forecast to reach USD 3.37 billion by 2030.

Which product category holds the largest share?

Prenatal supplements lead with 39.18% market share in 2024, reflecting sustained clinical emphasis on nutrient supplementation.

Which region is growing fastest?

Asia-Pacific is projected to post the highest 6.11% CAGR through 2030, driven by expanding healthcare access and rising disposable incomes.

How are digital technologies influencing product demand?

FDA-cleared wireless fetal monitors and AI-enabled wearables allow remote pregnancy management, accelerating premium demand among high-risk pregnancies.

What major restraint could dampen market growth?

Increasing reports of mislabeled prenatal supplements, highlighted by GAO investigations and FDA enforcement, may erode consumer trust and slow adoption.

Why are employers investing in maternal-wellness benefits?

Data from digital health platforms show programs can cut NICU admissions by 40% and lower emergency visits by 33%, translating to significant cost savings for employers.

Page last updated on:

Pregnancy Products Report Snapshots